Mesembrenol

Mesembrenol at a Glance

Mesembrenol is one of the four mesembrine-type alkaloids used to define and standardise kanna (Sceletium tortuosum) preparations, alongside mesembrine, mesembrenone and mesembranol. Structurally it is the C6-alcohol of mesembrenone — same 3a-aryl-cis-octahydroindole skeleton, but the ketone at position 6 reduced to a hydroxyl ^{1,10Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →Reference 10Patnala S · 2015Medicinal use of Sceletium: characterization of phytochemical components of Sceletium plant species using HPLC with UV and electrospray ionization–tandem mass spectroscopyView study →}.

It matters commercially more than it matters pharmacologically. The specification for the standardised extract Zembrin® is written partly around it — total alkaloids 0.35–0.45%, of which mesembrenone plus mesembrenol must be ≥60% and mesembrine <20% ^{5Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →} — and in one analysed batch mesembrenol was 32% of the total alkaloids, the second-largest single component ^{4Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →}. Wild kanna even runs a mesembrenol-dominant chemotype in which this alkaloid accounts for 65–96% of everything present ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →}.

Its individual pharmacology, by contrast, is genuinely thin, and that is stated rather than borrowing. There is exactly one clean isolate-level finding: in rat hippocampal slices, mesembrenol and mesembranol — the two congeners carrying a C6 hydroxyl rather than a carbonyl — attenuated AMPA-receptor-mediated transmission, which mesembrine and mesembrenone did not ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}. Everything else is either negative, in-silico, or belongs to a sibling molecule. Mesembrenol is not the serotonin-transporter blocker (that is mesembrine) and not the PDE4 inhibitor (that is mesembrenone).

Naming: Mesembrenol, Δ7-Mesembrenol and the Congeners

The mesembrine alkaloids are a set of near-identical molecules that differ only in the oxidation state at C6 and the position of a ring double bond, and the naming is a reliable source of error. Analytical papers that resolve them by mass and fragmentation give the family as ^{10Reference 10Patnala S · 2015Medicinal use of Sceletium: characterization of phytochemical components of Sceletium plant species using HPLC with UV and electrospray ionization–tandem mass spectroscopyView study →}:

Alkaloid	Formula	Nominal mass	C6 group
Mesembrenone	C₁₇H₂₁NO₃	287	ketone, unsaturated
Δ7-Mesembrenone	C₁₇H₂₁NO₃	287	ketone, double-bond isomer
Mesembrine	C₁₇H₂₃NO₃	289	ketone, saturated
Mesembrenol	C₁₇H₂₃NO₃	289	hydroxyl, unsaturated
Mesembranol	C₁₇H₂₅NO₃	291	hydroxyl, saturated
Epimesembranol	C₁₇H₂₅NO₃	291	hydroxyl, C6 epimer

Three distinctions are worth holding onto:

• Mesembrenol vs. Δ7-mesembrenol. The literature’s settled name is simply mesembrenol; “Δ7-mesembrenol” circulates as a variant and is listed here so searches land, but the Δ7 prefix properly belongs to Δ7-mesembrenone, a different compound — a double-bond positional isomer of mesembrenone, and one of the alkaloids that increases during traditional fermentation ^{11Reference 11Patnala S · 2009Investigations of the phytochemical content of Sceletium tortuosum following the preparation of “Kougoed” by fermentation of plant materialView study →}. Seeing “Δ7” in a kanna certificate of analysis usually means the mesembrenone isomer, not this molecule.
• Mesembrenol vs. mesembranol. Mesembranol is the fully reduced congener (no ring double bond). The two behave alike in the one assay where both were tested ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}, which is why they are frequently reported as a pair, but they are separate compounds with separate masses.
• Mesembrenol vs. its carboxylic-acid derivative. Mesembrenol-3-carboxylic acid is a distinct minor kanna alkaloid with essentially no pharmacology of its own, and should not be counted toward mesembrenol content. The same applies to mesembrenone-3-carboxylic acid.

A fourth trap sits outside Sceletium: the ornamental daffodil Narcissus cv. Hawera produces 6-epi-mesembrenol, a C6 epimer, not mesembrenol itself ^{16,17Reference 16Sidjimova B et al. · 2024Dynamics of alkaloid accumulation in Narcissus cvView study →Reference 17Berkov S et al. · 2021GC-MS analysis of Amaryllidaceae and Sceletium-type alkaloids in bioactive fractions from Narcissus cvView study →}.

Its Role in Extract Standardisation

Mesembrenol’s clearest claim on attention is regulatory rather than pharmacological. Kanna is chemically unruly — wild S. tortuosum varies from 0.11% to 1.99% total alkaloids by dry weight and sorts into distinct chemotypes, one of which is essentially devoid of mesembrine-type alkaloids while another is dominated by mesembrenol at 65–96% of the alkaloid fraction ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →}. Regional surveys find the same spread: Northern Cape material averaged 4,938–9,377 mg/kg total alkaloids, Western Cape material 16–4,143 mg/kg ^{12Reference 12Zhao J et al. · 2018Zhao J, Khan IA, Combrinck S, Sandasi M, Chen W, Viljoen AM (2018). ¹H-NMR and UPLC-MS metabolomics: functional tools for exploring chemotypic variation in Sceletium tortuosum from two provinces in South Africa. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/29783186/View study →}. Traditional fermentation into kougoed shifts the profile further, converting mesembrine toward Δ7-mesembrenone over about ten days under sunlight and aqueous conditions ^{11Reference 11Patnala S · 2009Investigations of the phytochemical content of Sceletium tortuosum following the preparation of “Kougoed” by fermentation of plant materialView study →}.

Zembrin® — the extract behind almost every human kanna trial — answers that variability with a specification that names mesembrenol explicitly: a hydroethanolic extract of a “mak” (mild) variety, standardised to 0.35–0.45% total alkaloids, with mesembrenone + mesembrenol ≥60% and mesembrine <20% ^{5Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →}. Independent chromatographic profiling of a Zembrin batch put the four alkaloids at mesembrenone 47.9%, mesembrenol 32%, mesembrine 13.2% and mesembranol 6.8% of total alkaloids ^{4Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →}, and UPLC-MS profiling likewise lists mesembrenol among Zembrin’s major compounds ^{14Reference 14Lepule K et al. · 2025Neuroprotective and neurorestorative properties of Mesembryanthemum tortuosum in a Parkinson’s disease zebrafish larvae modelView study →}.

The practical consequence: the standardised extract is deliberately low in the best-characterised alkaloid (mesembrine) and high in mesembrenone and mesembrenol. That is a formulation choice, and it means published Zembrin results cannot be read as mesembrine pharmacology — but neither can they be read as mesembrenol pharmacology, since the extract was never deconstructed in a human. Reference standards for these alkaloids are not commercially routine, which has historically made even the analytics hard ^{10,21Reference 10Patnala S · 2015Medicinal use of Sceletium: characterization of phytochemical components of Sceletium plant species using HPLC with UV and electrospray ionization–tandem mass spectroscopyView study →Reference 21Patnala S · 2008A capillary zone electrophoresis method for the assay and quality control of mesembrine in Sceletium tabletsView study →}.

What It's Used For

Mesembrenol has been tested as an isolate more often than most minor plant alkaloids — it appears by name in receptor panels, zebrafish behaviour, hippocampal electrophysiology and permeation work. It has mostly come back quiet. The exception is a single, specific and rather interesting electrophysiological result.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. All three rows are low by design: every one rests on preclinical isolate work, and two of the three include a null result. Nothing here reaches human evidence.

01Neuronal Excitability and AMPA-Receptor ModulationShaky24%One ex-vivo rat hippocampal-slice study of the pure alkaloid, with a clean structure-activity result and an explicit anti-epileptic hypothesis ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}

02Anxiolytic-Like BehaviourShaky16%Two isolate-level zebrafish studies that disagree — positive but sub-potent in one ^{2Reference 2Maphanga VB et al. · 2022Mesembryanthemum tortuosum L. alkaloids modify anxiety-like behaviour in a zebrafish modelView study →}, null at extract-equivalent concentration in the other ^{8Reference 8Gericke J et al. · 2024Sceletium tortuosum-derived mesembrine significantly contributes to the anxiolytic effect of Zembrin®, but its anti-depressant effect may require synergy of multiple plant constituentsView study →}

03Monoamine and Neurodegeneration TargetsShaky8%Tested on a receptor/enzyme panel without being named among the actives ^{3Reference 3Harvey AL et al. · 2011Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloidsView study →}; otherwise molecular docking only ^{15Reference 15Lepule K et al. · 2026AnimalZembrin® mitigates reserpine-induced motor dysfunction and oxidative stress in Parkinson’s disease: in vivo and in silico analysesView study →}, plus a chemotype-level inference ^{13Reference 13Kaschula CH et al. · 2025AnimalDifferential impact of extracts from distinct Sceletium tortuosum chemotypes on central neurotransmitter concentrations in C57BL/6 miceView study →}

Mechanisms

The load-bearing point is the C6 substitution rule: within one narrow chemical family, the alcohols (mesembrenol, mesembranol) and the ketones (mesembrine, mesembrenone) do different things ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}. That is the reason not to read a sibling’s data across, and it is also mesembrenol’s only original contribution to the pharmacology of this class.

Pharmacokinetics

There is no pharmacokinetic profile for mesembrenol. No absorption, distribution, metabolism, half-life or bioavailability figure has been published for the isolated alkaloid in any species, and no plasma concentration has ever been measured after a kanna dose.

The single relevant datum is a permeability study: across excised porcine tissue, the intestinal permeability of pure mesembrenol was lower than that of the highly permeable control caffeine but much higher than the poorly permeable control atenolol, and it permeated buccal and sublingual tissue less well than intestinal tissue ^{7Reference 7Shikanga EA et al. · 2012In vitroIn vitro permeation of mesembrine alkaloids from Sceletium tortuosum across porcine buccal, sublingual, and intestinal mucosaView study →}. Within the set, mesembrine permeated best (above caffeine) and mesembranol was comparable to caffeine, placing mesembrenol and mesembrenone at the lower end of the four ^{7Reference 7Shikanga EA et al. · 2012In vitroIn vitro permeation of mesembrine alkaloids from Sceletium tortuosum across porcine buccal, sublingual, and intestinal mucosaView study →}. The authors noted that oral-cavity transport may still contribute meaningfully when plant material is chewed and held in the mouth — the traditional kougoed practice — depending on pre-systemic metabolism, which for this molecule is entirely uncharacterised.

That gap is not cosmetic. Every finding above is an in-vitro or slice concentration; without a plasma or brain figure there is no way to know whether a mesembrenol-dominant kanna chemotype delivers enough of it to matter.

Clinical Trials

No clinical trial has ever administered mesembrenol. Every human study in this space used the standardised whole extract: a three-month randomised placebo-controlled safety and tolerability trial of Zembrin® at 8 mg and 25 mg daily ^{19Reference 19Nell H et al. · 2013RCTA randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adultsView study →}, a proof-of-concept cognition crossover at 25 mg/day ^{20Reference 20Chiu S et al. · 2014RCTProof-of-concept randomized controlled study of cognition effects of the proprietary extract Sceletium tortuosum (Zembrin) targeting phosphodiesterase-4 in cognitively healthy subjects: implications for Alzheimer’s dementiaView study →}, an acute anxiety challenge, and an amygdala fMRI study. Mesembrenol’s presence in those trials is as roughly a third of a ~0.4% alkaloid fraction ^{4,5Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →} — a component of the intervention, never the intervention.

Last checked: July 2026.

Isolate vs. Plant Studies

This molecule sits in an unusual position: the isolate has been tested repeatedly and mostly came back null, while the whole extract carries all the human evidence. Purified mesembrenol has gone through a receptor/enzyme panel ^{3Reference 3Harvey AL et al. · 2011Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloidsView study →}, two zebrafish behavioural designs ^{2,8Reference 2Maphanga VB et al. · 2022Mesembryanthemum tortuosum L. alkaloids modify anxiety-like behaviour in a zebrafish modelView study →Reference 8Gericke J et al. · 2024Sceletium tortuosum-derived mesembrine significantly contributes to the anxiolytic effect of Zembrin®, but its anti-depressant effect may require synergy of multiple plant constituentsView study →}, a hippocampal-slice electrophysiology series ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →} and a mucosal permeation assay ^{7Reference 7Shikanga EA et al. · 2012In vitroIn vitro permeation of mesembrine alkaloids from Sceletium tortuosum across porcine buccal, sublingual, and intestinal mucosaView study →}. Only the slice study produced a positive, mechanism-specific result attributable to mesembrenol itself ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}.

Meanwhile every human outcome — safety over three months ^{19Reference 19Nell H et al. · 2013RCTA randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adultsView study →}, cognitive set-flexibility ^{20Reference 20Chiu S et al. · 2014RCTProof-of-concept randomized controlled study of cognition effects of the proprietary extract Sceletium tortuosum (Zembrin) targeting phosphodiesterase-4 in cognitively healthy subjects: implications for Alzheimer’s dementiaView study →}, amygdala reactivity, acute anxiety — belongs to Zembrin®, a preparation in which mesembrenol is one of at least four active-candidate alkaloids plus a broader matrix ^{4,5Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →}. The most careful deconstruction attempt to date found that the extract’s anxiolytic-like effect tracked mesembrine and its antidepressant-like effect tracked no single alkaloid at all, implying whole-extract synergy ^{8Reference 8Gericke J et al. · 2024Sceletium tortuosum-derived mesembrine significantly contributes to the anxiolytic effect of Zembrin®, but its anti-depressant effect may require synergy of multiple plant constituentsView study →}. Two independent lines therefore argue against reading extract results onto this molecule: the mechanistic one (the C6 rule separates it from mesembrine and mesembrenone ^{1Reference 1Dimpfel W et al. · 2018AnimalEffect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampusView study →}) and the empirical one (isolate substitution failed ^{8Reference 8Gericke J et al. · 2024Sceletium tortuosum-derived mesembrine significantly contributes to the anxiolytic effect of Zembrin®, but its anti-depressant effect may require synergy of multiple plant constituentsView study →}).

The one place mesembrenol’s abundance might genuinely matter is chemotype selection. A mesembrenol-dominant wild chemotype ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →} is a materially different medicine from a mesembrine-dominant one, and mouse work on minor-alkaloid-rich chemotypes produced a neurochemical signature (noradrenaline up, GABA down) distinct from a commercial extract ^{13Reference 13Kaschula CH et al. · 2025AnimalDifferential impact of extracts from distinct Sceletium tortuosum chemotypes on central neurotransmitter concentrations in C57BL/6 miceView study →}. That is a testable hypothesis about this alkaloid; it has not been tested.

Prevalence in Nature

Mesembrenol is, for practical purposes, a kanna alkaloid. It occurs in Sceletium tortuosum (now often placed as Mesembryanthemum tortuosum), where the aerial parts are the material used, and was identified there alongside mesembrine and mesembrenone in fermented plant material by Smith and colleagues in 1998 ^{18Reference 18Smith MT et al. · 1998The distribution of mesembrine alkaloids in selected taxa of the Mesembryanthemaceae and their modification in the Sceletium derived ‘Kougoed’View study →}.

Within the species the concentration is governed by chemotype more than anything else. A survey of 151 wild specimens from 31 localities in south-western South Africa resolved five chemotypes: one devoid of mesembrine-type alkaloids, one dominated by mesembrine (51–93% of alkaloids), one by mesembrenone (51–73%), one intermediate — and one, chemotype B, dominated by mesembrenol at 65–96% of the total alkaloid fraction ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →}. Total alkaloid content across that wild material ranged from 0.11% to 1.99% of dry weight ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →}. A later two-province metabolomics study found Northern Cape plants averaging 4,938–9,377 mg/kg total alkaloids against 16–4,143 mg/kg for Western Cape material ^{12Reference 12Zhao J et al. · 2018Zhao J, Khan IA, Combrinck S, Sandasi M, Chen W, Viljoen AM (2018). ¹H-NMR and UPLC-MS metabolomics: functional tools for exploring chemotypic variation in Sceletium tortuosum from two provinces in South Africa. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/29783186/View study →}. Post-harvest processing shifts things again: controlled fermentation converts mesembrine toward Δ7-mesembrenone ^{11Reference 11Patnala S · 2009Investigations of the phytochemical content of Sceletium tortuosum following the preparation of “Kougoed” by fermentation of plant materialView study →}.

Outside Sceletium, the picture thins fast. Mesembrine-type alkaloids have been reported from other Mesembryanthemaceae including Delosperma (ice plant), but only at trace or below-detection levels, with no reliable quantification published ^{18Reference 18Smith MT et al. · 1998The distribution of mesembrine alkaloids in selected taxa of the Mesembryanthemaceae and their modification in the Sceletium derived ‘Kougoed’View study →} — a Delosperma preparation cannot be assumed to carry meaningful mesembrenol. Further afield, the ornamental daffodil Narcissus cv. Hawera biosynthesises Sceletium-type alkaloids and is an emerging source of the 6-epi- epimer: 6-epi-mesembrenol made up 16.2% of a lycorine-depleted alkaloid fraction ^{17Reference 17Berkov S et al. · 2021GC-MS analysis of Amaryllidaceae and Sceletium-type alkaloids in bioactive fractions from Narcissus cvView study →}, with dormant bulbs the richest organ and leaves of flowering plants the highest-yielding foliage ^{16Reference 16Sidjimova B et al. · 2024Dynamics of alkaloid accumulation in Narcissus cvView study →}. That is an epimer of mesembrenol, not the same molecule.

Discovery & Synthesis

The mesembrine alkaloids were opened up structurally in the early 1960s: Popelak and co-workers established (−)-mesembrine as an N-methyl-3a-(3′,4′-dimethoxyphenyl)-6-oxo-cis-octahydroindole, the scaffold every member of the family shares ^{9,18Reference 9Krstenansky JL · 2017ReviewMesembrine alkaloids: review of their occurrence, chemistry, and pharmacologyView study →Reference 18Smith MT et al. · 1998The distribution of mesembrine alkaloids in selected taxa of the Mesembryanthemaceae and their modification in the Sceletium derived ‘Kougoed’View study →}. Mesembrenol’s own first isolation is not separately well documented in the accessible literature — it emerges as a named component of Sceletium in the analytical work that followed, and its identification in fermented kanna alongside mesembrine and mesembrenone is credited to Smith and colleagues in 1998 ^{18Reference 18Smith MT et al. · 1998The distribution of mesembrine alkaloids in selected taxa of the Mesembryanthemaceae and their modification in the Sceletium derived ‘Kougoed’View study →}. The name is simply descriptive: mesembr- for the plant family, -en- for the ring unsaturation, -ol for the C6 alcohol that distinguishes it from mesembrenone.

No total synthesis of mesembrenol is prominently documented. Synthetic effort in this family has concentrated overwhelmingly on mesembrine, which has attracted dozens of routes as a benchmark for constructing the quaternary 3a-aryloctahydroindole centre; mesembrenol is most naturally reached by reduction of the mesembrenone carbonyl, but a defining published route was not identified. Supply today is extraction, not synthesis — the material used in research is purified from Sceletium plant material, and the persistent complaint in the analytical literature is that reference standards are not routinely commercially available, which is why several groups isolated and characterised their own markers before they could run quality control at all ^{10,21Reference 10Patnala S · 2015Medicinal use of Sceletium: characterization of phytochemical components of Sceletium plant species using HPLC with UV and electrospray ionization–tandem mass spectroscopyView study →Reference 21Patnala S · 2008A capillary zone electrophoresis method for the assay and quality control of mesembrine in Sceletium tabletsView study →}.

Patents: not yet researched.

Toxicity & Safety

Mesembrenol carries a low flag, but the flag is inherited rather than earned: it reflects the safety record of the plant and the standardised extract that contain it, because no toxicology study has ever been run on the isolated alkaloid. There is no acute LD₅₀, no repeat-dose study, no genotoxicity package and no human exposure data for mesembrenol alone.

What does exist is extract-level and reassuring. A standardised Sceletium extract showed no mortality or treatment-related adverse effects in Wistar rats, with a 14-day NOAEL of 5,000 mg/kg bw/day and a 90-day NOAEL of 600 mg/kg bw/day — both the highest doses tested ^{5Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →}. In humans, 8 mg and 25 mg of Zembrin® daily for three months produced no differences from placebo in vital signs, ECG, haematology, biochemistry or physical examination; headache was the commonest adverse event and occurred more often on placebo ^{19Reference 19Nell H et al. · 2013RCTA randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adultsView study →}. Mesembrenol was roughly a third of the alkaloid fraction of those doses ^{4,5Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →}.

The interaction concern for this class is pharmacodynamic, not metabolic: kanna preparations inhibit serotonin reuptake, so combining them with SSRIs, SNRIs, MAOIs or triptans risks additive serotonergic load, and the vasodilatory PDE4 activity argues against stacking with erectile-dysfunction or antihypertensive drugs. Both of those mechanisms trace to mesembrine and mesembrenone rather than to mesembrenol ^{3Reference 3Harvey AL et al. · 2011Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloidsView study →}, so the caution follows the preparation, not this molecule. No cytochrome-P450 or transporter interaction has been demonstrated for mesembrenol or for the extract. No reproductive or developmental toxicity study has been performed on the isolated alkaloid; decisions about intake in pregnancy or lactation belong on the kanna monograph, where a preparation is actually chosen.

Safety at a Glance

✅ Low / no toxicity

• No adverse signal at extract level. Three months of standardised Sceletium extract at 8–25 mg/day was indistinguishable from placebo on vitals, ECG and bloods ^{19Reference 19Nell H et al. · 2013RCTA randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adultsView study →}; rat NOAEL 600 mg/kg/day over 90 days ^{5Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →}.
• Serotonergic stacking is the real caution. Kanna preparations inhibit serotonin reuptake — avoid combining with SSRIs, SNRIs, MAOIs or triptans. The mechanism is mesembrine’s, but the exposure is the extract’s.
• The isolate is untested. No toxicology, genotoxicity, repeat-dose or reproductive study exists for mesembrenol on its own; the low flag is inherited from the plant, not measured for the molecule.
• Chemotype variability is a safety variable too. Wild kanna ranges from 0.11% to 1.99% total alkaloids and from zero to 96% mesembrenol ^{6Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →} — unstandardised material is not a known quantity.

Dosage

There is no dose of mesembrenol. It has never been administered to a human being as an isolated compound, and no isolate dosing range exists in any species.

For orientation, the figures below are whole-preparation research doses in which mesembrenol is one component among several — they are not mesembrenol doses, and they are not a personal recommendation.

Working from the specification — 0.35–0.45% total alkaloids, of which mesembrenol was 32% in one profiled batch ^{4,5Reference 4Gericke J et al. · 2022AnimalAn acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line ratView study →Reference 5Murbach TS et al. · 2014AnimalA toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in ratsView study →} — a 25 mg Zembrin® capsule contains on the order of 30–40 micrograms of mesembrenol. Traditional and non-standardised kanna preparations are a different matter entirely: dose, chemotype and fermentation all move the number, and a mesembrenol-dominant chemotype could deliver a hundredfold more or less than a mesembrine-dominant one at the same gram weight ^{6,11Reference 6Shikanga EA et al. · 2012The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulationsView study →Reference 11Patnala S · 2009Investigations of the phytochemical content of Sceletium tortuosum following the preparation of “Kougoed” by fermentation of plant materialView study →}. These are doses studied in research and are not a personal recommendation.

References

1. Dimpfel W, Franklin R, Gericke N, Schombert L (2018). Effect of Zembrin® and four of its alkaloid constituents on electric excitability of the rat hippocampus. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/29758341/
2. Maphanga VB, Skalicka-Wozniak K, Budzynska B, Skiba A, Chen W, Agoni C, Enslin GM, Viljoen AM (2022). Mesembryanthemum tortuosum L. alkaloids modify anxiety-like behaviour in a zebrafish model. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/35134486/
3. Harvey AL, Young LC, Viljoen AM, Gericke NP (2011). Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/21798331/
4. Gericke J, Lekhooa M, Steyn SF, Viljoen AM, Harvey BH (2022). An acute dose-ranging evaluation of the antidepressant properties of Sceletium tortuosum (Zembrin®) versus escitalopram in the Flinders Sensitive Line rat. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/34454055/
5. Murbach TS, Hirka G, Szakonyiné IP, Gericke N, Endres JR (2014). A toxicological safety assessment of a standardized extract of Sceletium tortuosum (Zembrin®) in rats. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/25301237/
6. Shikanga EA, Viljoen AM, Combrinck S, Marston A, Gericke N (2012). The chemotypic variation of Sceletium tortuosum alkaloids and commercial product formulations. Biochemical Systematics and Ecology. https://doi.org/10.1016/j.bse.2012.06.025
7. Shikanga EA, Hamman JH, Chen W, Combrinck S, Gericke N, Viljoen AM (2012). In vitro permeation of mesembrine alkaloids from Sceletium tortuosum across porcine buccal, sublingual, and intestinal mucosa. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/22105579/
8. Gericke J, Harvey BH, Pretorius L, Ollewagen T, Benecke RM, Smith C (2024). Sceletium tortuosum-derived mesembrine significantly contributes to the anxiolytic effect of Zembrin®, but its anti-depressant effect may require synergy of multiple plant constituents. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/37660956/
9. Krstenansky JL (2017). Mesembrine alkaloids: review of their occurrence, chemistry, and pharmacology. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/27939420/
10. Patnala S, Kanfer I (2015). Medicinal use of Sceletium: characterization of phytochemical components of Sceletium plant species using HPLC with UV and electrospray ionization–tandem mass spectroscopy. Journal of Pharmacy & Pharmaceutical Sciences. https://pubmed.ncbi.nlm.nih.gov/26626243/
11. Patnala S, Kanfer I (2009). Investigations of the phytochemical content of Sceletium tortuosum following the preparation of “Kougoed” by fermentation of plant material. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/18996176/
12. Zhao J, Khan IA, Combrinck S, Sandasi M, Chen W, Viljoen AM (2018). ¹H-NMR and UPLC-MS metabolomics: functional tools for exploring chemotypic variation in Sceletium tortuosum from two provinces in South Africa. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/29783186/
13. Kaschula CH, Engelbrecht AM, Makunga NP, Muller M, de Villiers A, Dube KM, Brand S, Stroebel JA, van Otterlo WA, Wolmarans W (2025). Differential impact of extracts from distinct Sceletium tortuosum chemotypes on central neurotransmitter concentrations in C57BL/6 mice. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/40374049/
14. Lepule K, Sandasi M, Chen W, Viljoen A (2025). Neuroprotective and neurorestorative properties of Mesembryanthemum tortuosum in a Parkinson’s disease zebrafish larvae model. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/40691887/
15. Lepule K, Sandasi M, Salifu E, Viljoen A (2026). Zembrin® mitigates reserpine-induced motor dysfunction and oxidative stress in Parkinson’s disease: in vivo and in silico analyses. Molecules. https://pubmed.ncbi.nlm.nih.gov/42451736/
16. Sidjimova B, Denev R, Nikolova M, Bastida J, Berkov S (2024). Dynamics of alkaloid accumulation in Narcissus cv. Hawera: a source of Sceletium-type alkaloids. Zeitschrift für Naturforschung C. https://pubmed.ncbi.nlm.nih.gov/38516999/
17. Berkov S, Pechlivanova D, Denev R, Nikolova M, Georgieva L, Sidjimova B, Bakalov D, Tafradjiiska R, Stoynev A, Momekov G, Bastida J (2021). GC-MS analysis of Amaryllidaceae and Sceletium-type alkaloids in bioactive fractions from Narcissus cv. Hawera. Rapid Communications in Mass Spectrometry. https://pubmed.ncbi.nlm.nih.gov/33928691/
18. Smith MT, Field CR, Crouch NR, Hirst M (1998). The distribution of mesembrine alkaloids in selected taxa of the Mesembryanthemaceae and their modification in the Sceletium derived ‘Kougoed’. Pharmaceutical Biology. https://doi.org/10.1076/phbi.36.3.173.6350
19. Nell H, Siebert M, Chellan P, Gericke N (2013). A randomized, double-blind, parallel-group, placebo-controlled trial of extract Sceletium tortuosum (Zembrin) in healthy adults. Journal of Alternative and Complementary Medicine. https://pubmed.ncbi.nlm.nih.gov/23441963/
20. Chiu S, Gericke N, Farina-Woodbury M, Badmaev V, Raheb H, Terpstra K, et al. (2014). Proof-of-concept randomized controlled study of cognition effects of the proprietary extract Sceletium tortuosum (Zembrin) targeting phosphodiesterase-4 in cognitively healthy subjects: implications for Alzheimer’s dementia. Evidence-Based Complementary and Alternative Medicine. https://pubmed.ncbi.nlm.nih.gov/25389443/
21. Patnala S, Kanfer I (2008). A capillary zone electrophoresis method for the assay and quality control of mesembrine in Sceletium tablets. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/18280080/

View all 21 references▾